Bibliography
- Banks DJ, Ward SC, Bradley KA. New insights into the functions of anthrax toxin. Expert Rev Mol Med 2006;8(7):1-18
- Bradley KA, Mogridge J, Mourez M, Identification of the cellular receptor for anthrax toxin. Nature 2001;414(6860):225-9
- Walsh JJ, Pesik N, Quinn CP, A case of naturally acquired inhalation anthrax: clinical care and analyses of anti-PA immunoglobulin G and LF. Clin Infect Dis 2007;44(7):968-71
- Friedlander AM, Pittman PR, Parker GW. Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax. JAMA 1999;282(22):2104-6
- Schneemann A, Manchester M. Anti-toxin antibodies in prophylaxis and treatment of inhalation anthrax. Future Microbiol 2009;4:35-43
- Vietri NJ, Purcell BK, Lawler JV, Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthrax. Proc Natl Acad Sci USA 2006;103(20):7813-6
- Klinman DM, Tross D. A single-dose combination therapy that both prevents and treats anthrax infection. Vaccine 2009;27(12):1811-5
- Grabenstein JD. Vaccines: countering anthrax: vaccines and immunoglobulins. Clin Infect Dis 2008;46(1):129-36
- Welkos S, Friedlander A, Weeks S, In-vitro characterisation of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody. J Med Microbiol 2002;51(10):821-31
- Migone TS, Subramanian GM, Zhong J, Raxibacumab for the treatment of inhalational anthrax. N Engl J Med 2009;361(2):135-44